Literature DB >> 27992767

Changes in cytokine and chemokine expression distinguish dysthymic disorder from major depression and healthy controls.

Pei-Shen Ho1, Che-Hung Yen2, Chun-Yen Chen3, San-Yuan Huang3, Chih-Sung Liang4.   

Abstract

An important area of uncertainty is the inflammatory degree to which depression occurring as part of dysthymic disorder may differ from major depression. Using a 27-plex cytokine assay, we analyzed the serum of 12 patients with dysthymic disorder, 12 with major depression, and an age-, sex-, and body mass index-matched control group of 20 healthy volunteers. We observed that patients with dysthymic disorder exhibited aberrant cytokine and chemokine expression compared with healthy controls and patients with major depression. The levels of interferon-γ-induced protein 10 highly predicted dysthymic disorder. Network analyses revealed that in patients with dysthymic disorder, the vertices were more sparsely connected and adopted a more hub-like architecture, and the connections from neighboring vertices of interleukin 2 and eotaxin-1 increased. After treatment with the same antidepressant, there was no difference between dysthymic disorder and major depression regarding any of the cytokines or chemokines analyzed. For dysthymic disorder, changes in the levels of interferon-γ-induced protein 10 and macrophage inflammatory protein-1α correlated with depression improvement. The findings suggest that the cytokine milieu in dysthymic disorder differs either at the level of individual expression or in network patterns. Moreover, chemokines play an important role in driving the pathophysiology of dysthymic disorder.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cytokine network; Dysthymia; Eotaxin-1; Inflammation; Interferon-γ-induced protein 10

Mesh:

Substances:

Year:  2016        PMID: 27992767     DOI: 10.1016/j.psychres.2016.12.014

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  9 in total

1.  Altered maternal immune networks are associated with adverse child neurodevelopment: Impact of alcohol consumption during pregnancy.

Authors:  Tamara S Bodnar; Charlis Raineki; Wladimir Wertelecki; Lyubov Yevtushok; Larisa Plotka; Natalya Zymak-Zakutnya; Gordon Honerkamp-Smith; Alan Wells; Matthieu Rolland; Todd S Woodward; Claire D Coles; Julie A Kable; Christina D Chambers; Joanne Weinberg
Journal:  Brain Behav Immun       Date:  2018-05-05       Impact factor: 7.217

2.  Inflammation and depression in young people: a systematic review and proposed inflammatory pathways.

Authors:  Yara J Toenders; Liliana Laskaris; Christopher G Davey; Michael Berk; Yuri Milaneschi; Femke Lamers; Brenda W J H Penninx; Lianne Schmaal
Journal:  Mol Psychiatry       Date:  2021-10-11       Impact factor: 15.992

Review 3.  Targeting the CCL2-CCR2 axis in depressive disorders.

Authors:  Katarzyna Curzytek; Monika Leśkiewicz
Journal:  Pharmacol Rep       Date:  2021-05-24       Impact factor: 3.024

4.  Immune-Regulatory and Molecular Effects of Antidepressants on the Inflamed Human Keratinocyte HaCaT Cell Line.

Authors:  Curzytek K; Maes M; Kubera M
Journal:  Neurotox Res       Date:  2021-05-04       Impact factor: 3.911

5.  25(OH)D levels are decreased in patients with difficult-to-treat depression.

Authors:  C Grudet; D Lindqvist; J Malm; Å Westrin; F Ventorp
Journal:  Compr Psychoneuroendocrinol       Date:  2022-02-09

6.  Comparison of LPS and MS-induced depressive mouse model: behavior, inflammation and biochemical changes.

Authors:  Xiaojin Yu; Hui Yao; Xiaohui Zhang; Lulu Liu; Shuangmei Liu; Youjing Dong
Journal:  BMC Psychiatry       Date:  2022-09-05       Impact factor: 4.144

Review 7.  Revisiting the Role of Eotaxin-1/CCL11 in Psychiatric Disorders.

Authors:  Antonio L Teixeira; Clarissa S Gama; Natalia P Rocha; Mauro M Teixeira
Journal:  Front Psychiatry       Date:  2018-06-14       Impact factor: 4.157

8.  The role of interleukin-33 in patients with mild cognitive impairment and Alzheimer's disease.

Authors:  Chih-Sung Liang; Kuan-Pin Su; Chia-Lin Tsai; Jiunn-Tay Lee; Che-Sheng Chu; Ta-Chuan Yeh; Ming-Wei Su; Guan-Yu Lin; Yu-Kai Lin; Hsuan-Te Chu; Chia-Kuang Tsai; Fu-Chi Yang
Journal:  Alzheimers Res Ther       Date:  2020-07-16       Impact factor: 6.982

Review 9.  Circulating plasma factors involved in rejuvenation.

Authors:  Jae Sook Kang; Yong Ryoul Yang
Journal:  Aging (Albany NY)       Date:  2020-11-16       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.